학술논문

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer
Document Type
Article
Source
In: Journal of Translational Medicine. (Journal of Translational Medicine, December 2023, 21(1))
Subject
Language
English
ISSN
14795876